Cryo-Save Group N.V. : Cryo-Save Group N.V. - Buyback of shares

       Cryo-Save Group N.V. : Cryo-Save Group N.V. - Buyback of shares

Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the
leading international stem cell storage company and the largest family stem
cell bank in Europe, announces that it has commenced a new tranche of its
share buyback programme.

Based on the authorization granted by the General Meeting of Shareholders on
16 May 2012, Cryo-Save intends to buy approximately 120,000 shares
representing 1.3% of its outstanding shares. This tranche of the share buyback
programme will have a maximum value of EUR 277,000 based on the stock price at
29 January 2013, and will be funded by the Group's existing cash reserves.

All shares acquired will be proposed for cancellation by the Board at the
upcoming Annual General Meeting on 15 May 2013.

The buyback programme will be executed by Kempen & Co.


Arnoud van Tulder, Chief Executive Officer + 31 (0) 575 509 100
Please click here for full press release in PDF


This announcement is distributed by Thomson Reuters on behalf of Thomson
Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
information contained therein.

Source: Cryo-Save Group N.V. via Thomson Reuters ONE
Press spacebar to pause and continue. Press esc to stop.